LOUISE GUNTER: Open Payments
NPI 1003858226 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,970 in 69 payments from 24 companies in 2025. Trend: 2023 $763 · 2024 $605 · 2025 $1,970
Food & beverage: $1,895Education: $75
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $384 |
| Janssen Biotech, Inc. | 11 | $231 |
| Novartis Pharmaceuticals Corporation | 11 | $218 |
| Stemline Therapeutics Inc. | 3 | $171 |
| GlaxoSmithKline, LLC. | 2 | $130 |
| Amgen Inc. | 1 | $123 |
| Merck Sharp & Dohme LLC | 4 | $92 |
| Astellas Pharma US Inc | 2 | $90 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| PFIZER INC. | 3 | $61 |
Products named: Orserdu, Enhertu, RYBREVANT, JEMPERLI, VECTIBIX, IMFINZI, KISQALI, KEYTRUDA.
Industry payments across TX — which companies pay providers there.
